Duke forum to address medical aspects of terrorism

November 15, 2001

DURHAM, N.C. -- A Nov. 26 forum hosted by Duke University Medical Center will examine what the medical community is doing to respond to and prepare for acts of terrorism.

The session, which is free and open to the public, is the eighth in a series of forums organized by Duke in the wake of the events of Sept. 11. The 90-minute forum begins at 7 p.m. in Von Canon rooms B and C in the Bryan Student Center on Duke's West Campus. Time will be provided for questions and answers.

The program will begin with comments from Dr. R. Sanders Williams, dean of the Duke University School of Medicine and vice chancellor for academic affairs at Duke University Medical Center. Dr. Barton Haynes, chair of the department of medicine at Duke University Medical Center and director of the Duke Human Vaccine Institute, and Dr. Joseph Heitman, associate professor of genetics, pharmacology and cancer biology and an investigator with the Howard Hughes Medical Institute, will moderate the forum, which will feature the following topics and speakers:

Medical aspects of bioterrorism - Dr. Keith Kaye, director of hospital infection control, Duke Hospital, and assistant professor, Division of Infectious Diseases;

Medical aspects of chemical toxins used in terrorism - Dr. Woodhall "Sandy" Stopford, assistant clinical professor, community and occupational medicine, Department of Community and Family Medicine;

Medical aspects of radiation in terrorism - Randy Jirtle, professor, Department of Radiation Oncology; and

Psychological responses to terrorism - John Fairbank, associate professor, Department of Psychiatry and Behavioral Sciences.
Previous forums at Duke discussed "The New War on Terrorism: Initial Assessments," "Christianity, War and Patriotism," "National Security and Civil Liberties: How to Strike the Balance?," "The Terrorism Crisis and the World Economy: What Effects, What Strategies?," "The Morality of War in Islamic and Christian Perspective," "The Technologies of Counterterrorism" and "Historians Reflect on the Current Crisis: International Perspectives."

Streaming video of the previous forums, along with links and other resources, are available at http://www.duke.edu/web/forums/

Duke University Medical Center

Related Radiation Articles from Brightsurf:

Sheer protection from electromagnetic radiation
A printable ink that is both conductive and transparent can also block radio waves.

What membrane can do in dealing with radiation
USTC recently found that polymethylmethacrylate (PMMA) and polyvinyl chloride (PVC) can release acidic substance under γ radiation, whose amount is proportional to the radiation intensity.

First measurements of radiation levels on the moon
In the current issue (25 September) of the prestigious journal Science Advances, Chinese and German scientists report for the first time on time-resolved measurements of the radiation on the moon.

New biomaterial could shield against harmful radiation
Northwestern University researchers have synthesized a new form of melanin enriched with selenium.

A new way to monitor cancer radiation therapy doses
More than half of all cancer patients undergo radiation therapy and the dose is critical.

Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer
Oncotarget Volume 11, Issue 4: In this study, locally advanced head and neck cancer patients undergoing definitive chemoradiation were randomly allocated to weekly cisplatin - radiation {CRT arm} or nimotuzumab -weekly cisplatin -radiation {NCRT arm}.

Breaking up amino acids with radiation
A new experimental and theoretical study published in EPJ D has shown how the ions formed when electrons collide with one amino acid, glutamine, differ according to the energy of the colliding electrons.

Radiation breaks connections in the brain
One of the potentially life-altering side effects that patients experience after cranial radiotherapy for brain cancer is cognitive impairment.

Fragmenting ions and radiation sensitizers
The anti-cancer drug 5-fluorouracil (5FU) acts as a radiosensitizer: it is rapidly taken up into the DNA of cancer cells, making the cells more sensitive to radiotherapy.

'Seeing the light' behind radiation therapy
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime.

Read More: Radiation News and Radiation Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.